Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Metastatic Nonsquamous Non-Small Cell Lung Cancer”
Approved 1
- RetifanlimabINCYTE CORPMetastatic Nonsquamous Non-Small Cell Lung Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.